E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers B > Headlines for BioDelivery Sciences International, Inc. > News item
Published on 8/4/2009 in the Prospect News Special Situations Daily.

BioDelivery Sciences shareholder Elliott reduces ownership to 9%

By Lisa Kerner

Charlotte, N.C., Aug. 4 - Elliott Associates, LP sold 263,575 shares of BioDelivery Sciences International, Inc. between July 24 and July 28 priced from $5.10 to $5.45 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Tuesday.

Between July 17 and July 22, Elliott sold 137,400 shares, a prior SEC filing said.

The investor beneficially owns 1,904,000 shares, or 9%, of the Morrisville, N.C.-based pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.